Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

4.83
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
4.30
Today|||52-Week Range
11.54
-53.82%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close4.83
Today’s open4.79
Day’s range4.70 - 4.88
Volume93,931
Average volume (3 months)143,636
Market cap$102.7M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratioNM
Price/Sales1,329.82
Price/Book1.27

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...0.000.00%
REPHRecro Pharma Inc0.000.00%
TRVNTrevena Inc0.000.00%
VCELVericel Corp0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 20, 2018
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts